Anticardiolipin antibody in patients with ischemic events - Journal of Mazandaran University of Medical Sciences
Volume 12, Number 37 (Dec 2002)                   J Mazandaran Univ Med Sci 2002, 12(37): 62-67 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaemian A, Nesar hosseini V, Mobini M, Ajami A. Anticardiolipin antibody in patients with ischemic events . J Mazandaran Univ Med Sci. 2002; 12 (37) :62-67
URL: http://jmums.mazums.ac.ir/article-1-340-en.html

Abstract:   (7039 Views)
Background and purpose: Ïn order to determine the presence of anticardiolipin (acl) antibodies in patients with ischemic events, a case control study was designed and performed.
Materials and methods: 33 patients with unstable angina, 33 male patients with myocardial infarction and 34 persons with no evidence of ischemic heart disease were selected for this study. Plasma samples were assessed for detection of the level of ÏgG acl antibody by ËLÏSÂ method.
Results : The level of cardiolipin (mean ± SD of optical density multiplied by 1000) for unstable angina, myocardial infarction patients and control subjects were 624 ± 3.19, 486 ± 318, and 239 ± 2.2 respectively. P=0.0001 and F=15.74.
Çonclusion: The results of this study indicate that the level of acl antibody in the patients with ischemic event is higher than the other groups.
Full-Text [PDF 149 kb]   (1135 Downloads)    
Type of Study: Research(Original) |

Add your comments about this article : Your username or email:
Write the security code in the box

© 2015 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb